From Ars Technica
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
TechTrends NowFollow the next shiftTechnology · Culture · ChangeTechTrends NowFollow the next shiftTechnology · Culture · ChangeFrom Ars Technica
The risk appears small and data is mixed, but FDA wants patients to be aware.